In our case, the expression of CD206 in the PEEK-PDA-Sr/AMP group was highest accompanied by a decrease in CD86 expression at 4 weeks postoperatively, suggesting that the potential of Sr/AMP co-modified PEEK can inhibit inflammatory infection response and enhance interfacial osseointegration. This evidence concerns the gene CD86 and infection.